Business Wire1 个月
Segal Trials Leads Phase 2 Schizophrenia Trial of LB-102 Toward Primary Endpoint
--(BUSINESS WIRE)--Segal Trials ... has released enrollment performance metrics from their participation in NOVA - a Phase 2 dose finding trial in adult patients with acute schizophrenia ...